Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium Plus Methimazole for Graves' Hyperthyroidism
NCT02727738Completed
- Sponsor
- University of Pisa
- Start
- Jan 2014
- Primary completion
- Sep 2015
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by University of Pisa. Primary endpoint: Control of hyperthyroidism at 90 days. Started Jan 2014; status: completed.
Beyond the preview
Go deeper on NCT02727738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02727738.